These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29168825)

  • 1. Disease progression: Divergent paths.
    DeWeerdt S
    Nature; 2017 Nov; 551(7681):. PubMed ID: 29168825
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis.
    Traussnigg S; Kienbacher C; Gajdošík M; Valkovič L; Halilbasic E; Stift J; Rechling C; Hofer H; Steindl-Munda P; Ferenci P; Wrba F; Trattnig S; Krššák M; Trauner M
    Liver Int; 2017 Oct; 37(10):1544-1553. PubMed ID: 28544208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease.
    Hudert CA; Selinski S; Rudolph B; Bläker H; Loddenkemper C; Thielhorn R; Berndt N; Golka K; Cadenas C; Reinders J; Henning S; Bufler P; Jansen PLM; Holzhütter HG; Meierhofer D; Hengstler JG; Wiegand S
    Liver Int; 2019 Mar; 39(3):540-556. PubMed ID: 30444569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease?
    Lee HW; Ahn SH
    J Gastroenterol Hepatol; 2020 Jun; 35(6):915-916. PubMed ID: 32537755
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperhomocysteinemia--a predictor of inflammatory changes in the liver].
    Zviagintseva TD; Hlushchenko SV
    Lik Sprava; 2014 Nov; (11):154-5. PubMed ID: 25528857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
    Mederacke YS; Kirstein MM; Großhennig A; Marhenke S; Metzler F; Manns MP; Vogel A; Mederacke I
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1160-1168. PubMed ID: 32323349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
    Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M
    World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.
    Anstee QM; Day CP
    Semin Liver Dis; 2015 Aug; 35(3):270-90. PubMed ID: 26378644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor: diagnosing fibrosis and cirrhosis in nonalcoholic fatty liver disease using machine learning models.
    Feng Y; Peng B; Li Y; Sun L; Sun Y
    Hepatology; 2023 May; 77(5):E103-E104. PubMed ID: 36645222
    [No Abstract]   [Full Text] [Related]  

  • 13. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
    World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity.
    Lahelma M; Luukkonen PK; Qadri S; Ahlholm N; Lallukka-Brück S; Porthan K; Juuti A; Sammalkorpi H; Penttilä AK; Arola J; Orho-Melander M; Yki-Järvinen H
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33429859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Genetic Variants to Improve Risk Prediction for NAFLD and Its Progression to Cirrhosis: A Proof of Concept Study.
    Vespasiani-Gentilucci U; Dell'Unto C; De Vincentis A; Baiocchini A; Delle Monache M; Cecere R; Pellicelli AM; Giannelli V; Carotti S; Galati G; Gallo P; Valentini F; Del Nonno F; Rosati D; Morini S; Antonelli-Incalzi R; Picardi A
    Can J Gastroenterol Hepatol; 2018; 2018():7564835. PubMed ID: 29732362
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Jones RB; Arenaza L; Rios C; Plows JF; Berger PK; Alderete TL; Fogel JL; Nayak K; Mohamed P; Hwang D; Palmer S; Sinatra F; Allayee H; Kohli R; Goran MI
    Nutrients; 2021 May; 13(5):. PubMed ID: 34065978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition in nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Clin Mol Hepatol; 2017 Mar; 23(1):1-12. PubMed ID: 28268262
    [TBL] [Abstract][Full Text] [Related]  

  • 19.  Estimated time from clinical presentation to the development of cirrhosis in non-cirrhotic adult patients with non-alcoholic fatty liver disease.
    Minuk GY; Sanders J; O'Brien M; Uhanova J
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):944-945. PubMed ID: 27740531
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.
    Zaharia OP; Strassburger K; Knebel B; Kupriyanova Y; Karusheva Y; Wolkersdorfer M; Bódis K; Markgraf DF; Burkart V; Hwang JH; Kotzka J; Al-Hasani H; Szendroedi J; Roden M;
    Diabetes Care; 2020 Sep; 43(9):2161-2168. PubMed ID: 32910776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.